The government is now operating in accordance with the Guidance on Caretaker Conventions, pending the outcome of the 2025 federal election.
Samsung Bioepis AU Pty Ltd
Regulatory activities for this sponsor.
Loading...
Sponsor content
2 result(s) found, displaying 1 to 2
-
Prescription medicine decision summaryOnbevzi (bevacizumab) is a biosimilar of Avastin. Onbevzi has been approved to treat a range of cancers either as a monotherapy or in combination with other anti-cancer medicines.
-
Prescription medicine decision summaryTGA decision: Byooviz (ranibizumab) is approved to treat visual impairment.